News Flashes (IGR: 25-3) | International Glaucoma Review

advertisement

Topcon

Topcon

News Flashes IGR 25-3

sustained intraocular pressure (IOP) reduction from a baseline of 28.8 mmHg to 15.8 mmHg (reduction of 42.6%), with a concomitant decrease from 1.9 to 0.8 medication types per eye

An active PA index category and a higher PA amount were associated with a slower rate of VF mean deviation (MD) loss in univariable analysis

Contrary to most prior observational studies, they conclude that thicker central corneas increase POAG liability

the risk ratio for developing glaucoma was 50.4% and 58.5%, respectively, indicating a 2-fold lower risk of developing POAG for those using GLP-1 drugs versus other weight loss therapies

This exemplifies the scarcity of population-based datasets on the prevalence of glaucoma in Africa in the last 2 decades, and still no sources from North and Central Africa.

portable perimetry could provide reliable data that independently or in combination with clinic-based current reference standard devices, was able to detect progression earlier then this may have significant benefits for glaucoma care

supplementation with these cofactors conferred robust structural and functional neuroprotection in both acute and chronic ocular hypertension models underpinning good potential for translation to glaucoma patients

antagonistic interactions were observed between prostaglandin F2α analog and beta-adrenergic blockers or Rho-associated protein kinase inhibitors

HPV infection was associated with a ~30 to ~60% increased risk of glaucoma (OAG, ACG, or both), depending on the models used.

The SIBS microshunt group demonstrated the best postoperative outcomes, with 69% achieving complete surgical success (medication-free IOP of 17 or less with no visually significant hypotony and reduction in IOP of at least 20%) as compared to 58% and 46%

a 1 SD increment in grip strength was associated with a 17% lower likelihood of prevalent glaucoma, and a <0.2 µm increment in macular GCIPL thickness

early functional decline may forecast long-term progression even in earlier disease stages

Issue 25-3

Table of Contents Editor's Selection

Change Issue

advertisement

WGA Rescources